Clinical trial
Phase 1 Study of L-NMMA in Patients With Liver Cirrhosis
NCT00344916 · Regional Hospital Holstebro, Other · Completed
Key facts
| NCT number | NCT00344916 |
|---|---|
| Title | Phase 1 Study of L-NMMA in Patients With Liver Cirrhosis |
| Official title | NO-Synthesis in Patients With Liver Cirrhosis: Effect of L-NMMA on Renal Hemodynamics, Sodium Excretion and Plasma Levels of Vasoactive Hormones |
| Lead sponsor | Regional Hospital Holstebro, Other |
| Status | Completed |
| Phase | Phase 1 |
| Study type | Interventional |
| Conditions | Liver Cirrhosis |
| Intervention type | Drug |
| Interventions | Ng-monomethyl-L-arginine (drug) |
| Enrollment | 30 |
| First posted | Jun 27, 2006 |
| Last update posted | Jul 11, 2006 |
At a glance
- No Results posted
- None Linked FDA submissions
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About ClinicalTrials.gov studies
ClinicalTrials.gov is the U.S. National Library of Medicine's registry of clinical studies conducted around the world. Contact and investigator details are not shown here.
Source: U.S. National Library of Medicine (NLM), ClinicalTrials.gov · Source date: